-
July 21, 2022 Discovery of a new therapeutic avenue targeting the cell cycle in a subtype of acute myeloid leukemia
The project, led by research officer Céline Moison, was published in the journal Blood Advances. The work was carried out in collaboration with the teams of Guy Sauvageau and Anne Marinier at IRIC, Josée Hébert at Hôpital Maisonneuve-Rosemont and Vincent-Philippe Lavallée at CHU Sainte-Justine.
-
July 19, 2022 Four IRIC researchers obtain funding from the Canadian Institutes of Health Research
Resulting from the most recent research grant competition of the Canadian Institutes of Health Research (CIHR), four IRIC researchers obtained funds via the Project grant program.
-
July 8, 2022 Five IRIC graduates named to the Honor List of the Rector of the Université de Montréal
IRIC is proud to count five of its graduates among the most recent appointments to the Rector’s Honor List.
-
July 5, 2022 Three IRIC researchers receive funding from the Natural Sciences and Engineering Research Council of Canada
The Natural Sciences and Engineering Research Council of Canada (NSERC) recently announced the results of its 2022 Research Grant Competition. More than $430 million will be awarded to researchers across the country to their research programs well. Three IRIC investigators were awarded grants.
-
June 29, 2022 IRIC recruits Dr. Vincent Q. Trinh to be a Principal Investigator
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to welcome aboard a new Principal Investigator in the Digital Histology and Advanced Pathology Research Unit, Dr. Vincent Q. Trinh, who will take up his position on July 1st, 2022.
-
June 29, 2022 Meet Vincent Q. Trinh, new Principal Investigator at IRIC
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to welcome aboard a new Principal Investigator in the Digital Histology and Advanced Pathology Research Unit, Dr. Vincent Q. Trinh, who will take up his position on July 1st, 2022. Dr. Trinh enthusiastically agreed to answer a few questions.
-
June 27, 2022 Hyperactivation of the NOTCH1 pathway in T-cell acute lymphoblastic leukemia: two recent publications bring new insights
The team of Trang Hoang, director of the Hematopoiesis and Leukemia Research Unit at IRIC, focused on the hyperactivation of NOTCH1 in T-ALL. The work of Diogo Veiga, postdoctoral fellow now professor of Genomics and Bioinformatics at the Universidade Estadual de Campinas in Brazil, and Mathieu Tremblay, research advisor, has led to the publication of two articles.
-
June 21, 2022 2022 IRIC Next Generation Awards : twelve interns will train at IRIC this summer
Twelve students have the opportunity to complete a research internship for 12 or 16 weeks at IRIC, and to receive a scholarship of excellence of respectively $4,800 or $6,400.
-
June 21, 2022 A 2022 edition in person for the IRIC Student Recruitment Event
The 2022 edition took place from June 1 to 3 and welcomed 29 participants from 18 universities around the world. 153 interviews were scheduled this year between participants and the 14 Institute researchers present at the event.
-
June 8, 2022 Nine next generation scientists from IRIC receive a training award from the Fonds de recherche du Québec
The Fonds de recherche du Québec (FRQ) awarded $39.3 million in training grants for its 2022-2023 competitions. IRIC is proud to count nine scientists from its next generation among the recipients of these competitions.
-
May 26, 2022 Claude Perreault and Pierre Thibault, founders of Epitopea, a company that offers hope for the treatment of cancer
Founded in 2021, the transatlantic biotechnology company Epitopea is the result of collaborations between the teams of Claude Perreault and Pierre Thibault, both principal investigators at IRIC. The mission of Epitopea is to develop immunotherapies to treat different types of cancers by targeting a new class of antigens.
-
May 20, 2022 3 million in support from the Stem Cell Network to study new ways to use blood stem cells in the treatment of leukemia
Guy Sauvageau, principal investigator at IRIC, hematologist and full professor in the Department of Medicine of the Faculty of Medicine of the Université de Montréal, is the recipient of major funding worth $3 million over three years. The project led by Dr. Sauvageau is composed of eight research groups, including those of Philippe Roux and Étienne Gagnon, both researchers at IRIC.
-
May 16, 2022 Vincent Archambault appointed Full Professor in the Department of Biochemistry and Molecular Medicine at the Université de Montréal
IRIC is proud to announce the promotion of Vincent Archambault, Principal Investigator and Director of the Cell Cycle Regulation Research Unit, as Full Professor in the Department of Biochemistry and Molecular Medicine at the Université de Montréal.
-
May 12, 2022 Les Rendez-vous Audace 2022: Dr. Eralda Kina answers your questions
Les Rendez-vous Audace of the IRIC, held on April 27, brought together André Robitaille and three inspiring speakers around the theme “A world in transformation, a next generation in action”. Eralda Kina, oncologist and doctoral student at IRIC in the laboratory of Claude Perreault, discussed her experience as a clinician and the great hopes she has in immunology and cancer research. Dr. Kina generously agreed to answer the questions received from the public during the broadcast of Les Rendez-vous Audace.
-
May 9, 2022 Geneviève Deblois Honoured by the Canadian Institutes of Health Research
Geneviève Deblois, Principal Investigator at IRIC and Assistant Professor at the Faculty of Pharmacy of the Université de Montréal, is the recipient of the Early Career Investigator in Cancer Award 2022. This award, presented by the Institute of Cancer Research of the Canadian Institutes of Health Research (CIHR), recognizes excellence in research conducted in Canada. It is awarded to the top-ranked new investigators in the CIHR fall competition, Project Scheme.
-
April 28, 2022 Identification of a new key role for interphase microtubules at mitosis entry
At the beginning of cell division, cells round-up through different mechanisms, notably the reorganization of their cortex. Among the proteins involved in this cell morphogenesis, there is the family of ERM proteins (ezrin, radixin and moesin). The team of Professor Sébastien Carréno, Director of the Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility Research Unit, wanted to identify the molecular cue activating these proteins at mitotic entry. Their work has shed light on a novel mechanism involving interphase microtubules in the regulation of cell rounding at mitotic onset. The project, led by PhD student Kévin Leguay, is the subject of a publication in the Journal of Cell Biology.
-
April 20, 2022 New agreement for an international research collaboration in drug discovery
IRIC is pleased to announce the signing of a collaboration agreement between Ono Pharmaceutical Co, Ltd., one of the largest clinical stage pharmaceutical companies in Japan, Domain Therapeutics S.A. and the Université de Montréal to discover novel small molecules targeting G protein-coupled receptors (GPCRs) for the treatment of metabolic diseases.
-
April 12, 2022 Publication of two studies characterizing the selectivity of G protein-coupled receptors’ coupling
Two-thirds of human hormones and one-third of clinical drugs target and activates the G protein-coupled receptors. For a given receptor, different ligands can selectively engage different subsets of signaling pathways. Mapping the effectors that can be engaged by a given receptor is essential for understanding physiological processes as well as for designing safer drugs. The team of Professor Michel Bouvier, Director of the Molecular Pharmacology Research Unit and Chief Executive Officer of IRIC, worked on characterizing the coupling selectivity of GPCRs.
-
March 7, 2022 IRIC celebrates International Women’s Day
IRIC is taking advantage of International Women’s Rights Day to recognize and highlight the exceptional contribution of all its scientists who work to make a difference.
-
February 24, 2022 Appointment of William Brock on the IRIC’s Board of Directors
IRIC announces the appointment of William Brock, Lawyer Emeritus of the Québec Bar Association, to its Board of Directors.
-
February 23, 2022 Assya Trofimov, Ph.D. student at IRIC, is the recipient of the prestigious Mahan postdoctoral fellowship.
Assya Trofimov, a Ph.D. student being co-directed in the laboratories headed by Dr. Claude Perreault and by Sébastien Lemieux, was awarded the prestigious Mahan postdoctoral fellowship. The competition, held annually by the Fred Hutchison Cancer Research Center (Fred Hutch) in Seattle, awards outstanding candidates by providing a 21-month stipend to carry out a research project in one of its Computational Biology laboratories.
-
February 17, 2022 Three sporting events for the benefit of IRIC
In 2022, IRIC community will have the opportunity to participate in three renowned sporting events: Les Défis du Parc national de la Mauricie, The Grands Prix Cyclistes de Québec et de Montréal, and the Marathon Beneva de Montréal.
-
February 11, 2022 IRIC marks the 2022 International Day of Women and Girls in Science
On this symbolic day, IRIC is proud to mark the exceptional contribution to cancer research made by all of its women members.
-
February 4, 2022 Four IRIC researchers receive Canadian Institutes of Health Research grants
In the Fall 2021 competition, four IRIC research teams were awarded prestigious grants.
-
February 4, 2022 The life lesson of marathoner Jean Mireault
On this World Cancer Day, IRIC would like to point out the generous contribution to our cause made by Mr. Jean Mireault. On October 11, 2021, Mr. Mireault ran in the Boston Marathon in honor of his mother, who died of cancer at a very young age. Although his race did not unfold as he had hoped because of an unexpected issue at the midway mark, Mr. Mireault drew a very inspiring lesson from the experience for all of us. Speaking very frankly, he describes the state of mind that he was in when he managed to complete, not without struggling, the second part of his marathon.
-
January 28, 2022 Renewal of Michel Bouvier’s mandate as Chief Executive Officer of IRIC
Following a meeting of the Executive Committee, held on December 7, the Université de Montréal announced the continuation of Michel Bouvier’s mandate as Chief Executive Officer of IRIC for a third one-year term.
-
January 27, 2022 IRIC obtains major funding to develop an intelligent chemolibrary
As part of the initial phase of Médicament Québec, IRIC recently obtained major funding of $3,200,045 for the Expanded Capacity and Quality of Chemolibraries for Drug Discovery Project.
-
January 26, 2022 Katherine Borden awarded by the Canadian Society for Molecular Biosciences
The Canadian Society for Molecular Biosciences (CSBM) awarded the prestigious 2022 Canadian Science Publishing Senior Investigator Award to Katherine Borden, Principal Investigator at IRIC and Full Professor in the Department of Pathology and Cell Biology at the Faculty of Medicine of the Université de Montréal.
-
January 20, 2022 Significant support from the National Institutes of Health to study new ways to target Acute Myeloid Leukemia
Professor Katherine Borden, Principal Investigator leading the Structure and Function of the Cell Nucleus Research Unit at IRIC, received a grant worth US$1.47 million (C$1.85 million) over five years. This funding from the National Institutes of Health (NIH), the largest biomedical research granting agency in the United States, will support her research project aimed at elucidating the molecular mechanisms of eIF4E-mediated tumor transformation.
-
January 18, 2022 Identification of a new oncogenic signaling pathway in the development of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third deadliest cancer in the world. Despite these impressive numbers, the few treatments currently available have only modest effects in affected patients, who are often diagnosed at a late stage of the disease. A better mechanistic understanding of HCC development is required to develop novel targeted therapies that work more efficiently. The team of Professor Sylvain Meloche, Director of the Cell Signaling and Cell Growth Research Unit at IRIC, recently shed light on a previously unknown oncogenic signaling pathway for HCC. Jean-Philippe Guégan and Marjorie Lapouge are the co-first authors of the article published in January in the journal Science Signaling.
-
December 14, 2021 IRIC Master’s and Ph.D. Scholarships – Recipients of the Fall 2021 Competition
As part of the IRIC Master’s and Ph.D. Scholarships Competition held this fall, the Institute is proud to announce the 14 recipients of this edition.
The objective of the competition is to support IRIC students with an outstanding academic and research record, but who do not benefit from any other substantial scholarships.
Congratulations to all the recipients!
-
December 13, 2021 IRIC, a key player in the Acuité-Québec project: $27M to accelerate the discovery of new drugs
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is delighted to be part of the Acuité-Québec project, an initiative aimed at fostering the discovery of new drugs.
-
November 16, 2021 Recruitment of IRIC’s Scientific Director
The IRIC invites applications for the position of Scientific Director and Principal Investigator at the Institute. IRIC seeks an established scientist with an exceptional track-record who will oversee the scientific development of the institute while leading his/her own basic and/or translational research program in cancer-relevant areas.
-
November 15, 2021 Organize a fundraising activity to support research in cancerology
On this National Philanthropy Day, IRIC is giving access to a new online tool for anyone wishing to organize a fundraising activity to support the Institute.
-
September 30, 2021 Trang Hoang receives the prix Mentor scientifique 2021 from the Club de Recherches Cliniques du Québec
Trang Hoang, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) and Full Professor in the Department of Pharmacology of the Faculty of Medicine of the Université de Montréal, has been awarded the prix Mentor scientifique 2021 (2021 Mentor Award) by the Club de Recherches Cliniques du Québec (CRCQ).
-
September 21, 2021 A forum for Gender Equality Week in Canada
As an institution, IRIC seeks to promote equity and increase diversity and inclusion, in all of its forms, throughout its programs.
-
July 29, 2021 Pierre Thibault’s team shares its knowledge on mass spectrometry-based proteomic strategies used to study UBL like modifications
The group of Pierre Thibault, Principal Investigator at IRIC and professor in the Department of Chemistry of UdeM, with a colleague from Leiden University Medical Center in the Netherlands, recently published an exhaustive review article in Nature Reviews Methods Primers to educate researchers of all levels on the variety of mass spectrometry-based proteomic strategies used to study ubiquitin-like (UBL) modifications and the type of information that can be generated through these approaches.
-
June 21, 2021 Brian Wilhelm awarded with major funding through the new Genomics Integration Program – Human Health initiated by Génome Québec
Brian Wilhelm, Principal Investigator at IRIC and Associate Professor in the Department of Medicine at the Faculty of Medicine of the Université de Montréal, is the recipient of major funding through the new Genomics Integration Program – Human Health, initiated by Génome Québec in collaboration with the Oncopole.
-
June 17, 2021 IRIC salutes the Quebec government for its commitment: $13M invested to bring together the players in the drug discovery and production field
IRIC is delighted by the creation of “Médicament Québec”, a major strategic hub whose mission is to promote greater autonomy and increase Quebec’s drive with respect to drug discovery, development and production.
-
June 3, 2021 Appointment of Clarissa Desjardins and renewal of Robert Paré and Jacques Bernier’s mandate on the IRIC’s Board of Directors
IRIC is pleased to announce the appointment of Dr. Clarissa Desjardins as a new member of the Board of Directors as well as the renewal of Mtre Robert Paré and Mr. Jacques Bernier’s mandate as a member of the Board by the Executive Committee of the Université de Montréal.
-
May 26, 2021 IRIC participates in the next Forum of the Chamber of Commerce of Metropolitan Montreal
On Monday, May 31, IRIC will take part in the Strategic Forum Universities, CEGEPs, businesses: Working together for a strong, innovative and socially responsible economy, an initiative co-developed by the Chamber of Commerce of Metropolitan Montreal and the FRQs.
-
May 17, 2021 Trang Hoang is the recipient of the 2021 CSMB Jeanne Manery Fisher Award
Trang Hoang, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) and Full Professor in the Department of Pharmacology at the Faculty of Medicine of the Université de Montréal is the recipient of the 2021 Canadian Society for Molecular Biosciences (CSMB) Jeanne Manery Fisher Award.
-
May 14, 2021 Les Rendez-vous Audace 2021: $320,000 raised to support IRIC’s cancer research efforts
Exceptionally this year, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal presented a virtual formula of its traditional Audacious fundraising event: Les Rendez-vous Audace. For the occasion, approximately 615 people from 8 countries attended the three free conferences and close to 20 sponsors supported the event. Thanks to the generosity of our partners and donors, a total of $320,000 was raised to accelerate the discovery of better therapies for the benefit of patients.
-
May 11, 2021 Lecture by Dr. Roger D. Kornberg – Nobel Prize in Chemistry
On May 20th, IRIC and the Université de Montréal will have the honour of welcoming Dr. Roger D. Kornberg, Nobel Prize in Chemistry in 2006. He will present a lecture titled “Chromosome Structure and Transcription”.
-
April 26, 2021 Genome-wide screens identify a novel gene that tapers the DNA damage response in human cells with eroded telomeres
Telomeres are DNA sequences that serve as critical caps to protect the ends of chromosomes against degradation, fraying, and fusion with other chromosomes. They play an important role in maintaining genome integrity but in most cells in our body, telomeres become shorter with each cell division as the activity of the telomere maintenance enzyme (TERT) is repressed. After sufficient telomere shortening, the protective telomere structure is lost, activating the tumor-suppressor gene p53 and the DNA damage response. This leads to a non-proliferative state in normal cells called senescence, or to cell death in cancer cells. These inhibitory effects upon cell proliferation are thought to be an important mechanism to prevent the proliferation of damaged cells and the formation of tumors.
-
April 26, 2021 A pathogenic yeast has many tricks up its sleeve
Infections with the yeast Candida albicans are a significant public health problem and a common complication in immunocompromised individuals such as people with AIDS, chemotherapy patients, and organ transplant patients. Although there are some treatments, their effectiveness can be compromised by the emergence of resistant strains and the identification of new antifungals is highly desirable. A few years ago, an IRIC team identified nicotinamide (NAM), a form of vitamin B3, as a potential antifungal treatment.
-
April 21, 2021 Talk from Guy Sauvageau at the CCMM
Leveraging innovation and collaboration to accelerate scientific discoveries in oncology
-
April 13, 2021 Spatiotemporal coordination: a key aspect allowing cells to divide correctly
Enzymes that regulate cell division must be subjected to spatiotemporal control, allowing them to access the cellular structures they control only at the appropriate time. The segregation of chromosomes during mitosis is the most crucial event of cell division. Spatiotemporal coordination is therefore fundamental to the good progress of mitosis but it remains poorly understood.
-
April 1, 2021 TMEM16F: a protein with a key role in the regulation of T cell activity
By Fatéma Dodat
Understanding the regulation of T cell activity is crucial for the development of immunity against infections, but also in cancer. A study conducted by the team of Etienne Gagnon reveals that TMEM16F, a molecule that promotes the exchange of components between the lipid bilayer of a cell membrane, is involved in this activation.
-
March 30, 2021 One step closer to developing a cancer vaccine
Claude Perreault and his team published an important article related to the development of a therapeutic cancer vaccine for a type of blood cancer.
-
February 26, 2021 A new way beckons to treat severe obesity
By Mathieu-Robert Sauvé, UdeM Nouvelles
Michel Bouvier, unveils research that could someday lead to treatment for early morbid familial obesity.
-
February 17, 2021 Michel Bouvier, CEO of IRIC, takes part in the Pan-Canadian Showcase on the future of drug discovery and production in Canada
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that Michel Bouvier, CEO of the Institute and recent recipient of the Killam Prize in Health Sciences, is taking part in the virtual event “Building Biotech: Science and Talent Accelerating Biomedical Innovation, a Pan-Canadian Showcase and Dialogue”.The Showcase is being held today, February 17, 2021, and is organized by PRiME at the University of Toronto.
-
February 4, 2021 2021 World Cancer Day: Help us vanquish cancer!
February 4 is World Cancer Day. Every year, it’s a day that is celebrated all over the world to highlight the incredible advances in cancer research that help save more and more lives and create undeniable hope. In memory of those we love who have left us too soon or in honour of those who are currently fighting the disease, let’s all highlight this Day, the progress that we have made and the progress left to be made.
-
February 3, 2021 Michel Bouvier is the laureate of the 2021 Killam Prize in Health Sciences
Michel Bouvier, CEO of IRIC and Professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de Montréal, is the laureate of the 2021 Killam Prize in Health Sciences.
-
January 26, 2021 IRIC Master’s and Ph.D. Scholarships – Recipients of the Fall 2020 Competition
As part of the IRIC Master’s and Ph.D. Scholarships Competition held this fall, the Institute is proud to announce the 17 recipients of this edition.
-
January 12, 2021 UM171: the molecule that keeps on giving
In a study published in Cell Stem Cell, a research team of 15 scientists led by UdeM hematologist Guy Sauvageau demonstrates the cancer-fighting molecule’s mechanism of action.
-
December 2, 2020 Nanotechnologies: the Bouilly lab reveals important principles in the design of biocaptors
In the past decades, advances in the field of nanotechnology, especially through the discovery and production of new nanomaterials, have catalyzed remarkable innovation in the creation of different biosensors, which are analytical devices used to detect and study the properties of many biological molecules. There are many types of biosensors and it is often difficult to compare their performance and identify the most promising approaches.
-
November 9, 2020 Sébastien Lemieux and his team’s project is a recipient of the ODAC Competition
Génome Québec, IVADO and Oncopole have come together to organize the “Omics Data Against Cancer” (ODAC) Competition. This initiative aims to support projects developing applications and artificial intelligence tools used to better exploit the datasets generated by genomics and the study of cancer.
The project of Sébastien Lemieux, Principal Investigator at IRIC and his team is one of the 5 recipient projects of the program.
-
October 20, 2020 IRIC’s Academic Affairs team receives the prix d’excellence en enseignement
IRIC is proud to announce that the prix d’excellence en enseignement Catégorie Innovation – Soutien à la réussite étudiante has been awarded to its Academic Affairs team: Sébastien Carréno, Julie Mantovani, Evelyne Muhire, Pascale Le Thérizien. This recognition bestowed by the Vice-Rector of Student and Academic Affairs of the Université de Montréal underscores the outstanding contribution made by the team to student success.
-
October 15, 2020 2020 student recruitment tour: a virtual edition this fall
Each fall, the IRIC’s Academic Affairs team launches an “IRIC on the road” student recruitment tour. This year, in the exceptional context caused by the COVID-19 pandemic, our representatives are going to meet students virtually. They will participate in several graduate studies fairs organized on the web by various Canadian universities.
-
October 14, 2020 A donation benefiting IRIC and the Department of Biochemistry and Molecular Medicine of the UdeM
As part of a major planned donations campaign, led by the Réseau des diplômés et des donateurs de l’Université de Montréal, Michel Bouvier, Chief Executive Officer of IRIC and his partner, Muriel Aubry, announced their testamentary donation benefiting IRIC and the Department of Biochemistry and Molecular Medicine of the UdeM, in support of cancer research and the training of the next generation of scientists.
-
October 13, 2020 Breaking the RNA capping paradigm
This discovery by a team of IRIC researchers could soon be taught in molecular biology courses. Katherine Borden’s laboratory recently published a study in the journal PNAS that demonstrated that the activity of RNAs can be regulated in a new way: by modulating a RNA modification known as capping.
-
September 4, 2020 Three IRIC researchers receive substantial support from the Canada Foundation for Innovation
On August 18, 2020, the Canada Foundation for Innovation (CFI) announced the selected research projects that will benefit from its financial support. This substantial support allows researchers to acquire highly specialized avant-garde equipment and infrastructure, and to recruit and retain internationally renowned scientists.
-
August 6, 2020 Genome-wide screens reveal that resveratrol induces replicative stress in human cells
Resveratrol (RSV) is a natural compound found in many plants, including the skin of grapes (and in wine), blueberries, raspberries, mulberries and peanuts. It has attracted considerable research attention due to its reported beneficial properties in experimental models such as yeasts, nematode worms, fruit flies and mice, including lifespan extension under certain conditions. A causal role of RSV in human health has not yet been established.
-
June 22, 2022 Michel Bouvier appointed Knight of the Ordre national du Québec
On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology Research Unit and Professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de Montréal, is appointed Knight of the Ordre national du Québec.
-
May 13, 2022 SQSV 2022-2025: Encouraging news for the industry!
IRIC is pleased with the announcement of the Quebec Minister of Economy and Innovation, Mr. Pierre Fitzgibbon, regarding the unveiling of the Quebec Life Sciences Strategy 2022-2025 during the renowned event Effervescence. Under the theme “Using our ingenuity to advance health”, the strategy, updated in the context of COVID-19, proposes concrete and innovative actions to promote this key industry of the Quebec economy and encourage its growth.
-
January 24, 2022 Investing in research: a move that pays off
A possible therapeutic ovarian cancer vaccine, a new treatment to fight leukemia and a molecule that could even short-circuit up to 70% of all types of cancers… These three projects, currently under development at IRIC, benefited from funds provided through private donations. Among them, publicly traded securities are a beneficial way to contribute to the next generation of cancer treatments.
-
October 4, 2021 -
September 22, 2021 2021 student recruitment tour: again, a virtual edition this fall
Each fall, the IRIC’s Academic Affairs team launches an “IRIC on the road” student recruitment tour. This year, our representatives are going to meet students virtually. They will participate in several graduate studies fairs organized on the web by various Canadian universities.
-
June 3, 2021 Fonds vaccin thérapeutique contre le cancer: Donations that make a real difference
In early 2020, IRIC created its brand new “Fonds vaccin thérapeutique contre le cancer”, a fund initiated by Dr. Robert Patenaude with a personal contribution of $25,000. The objective was to support the scientists involved in the project, namely the team led by Dr. Claude Perreault, in collaboration with the teams led by Sébastien Lemieux and Pierre Thibault, who work tirelessly to change the life of people affected by cancer.